Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 357, Issue 6, 1998, Pages 600-610

  Rueter, Lynne E ^a   Kasamo, Kimihiro ^a   De Montigny, Claude ^a   Blier, Pierre ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

2 Adrenergic autoreceptor; 2 Adrenergic heteroreceptor; 5 HT transporter; 3H 5 HT release; 3H NA release; NA transporter; Terminal 5 HT autoreceptor

Indexed keywords

5 METHOXYTRYPTAMINE; ANTIDEPRESSANT AGENT; AUTORECEPTOR; BRIMONIDINE; CARRIER PROTEIN; DESIPRAMINE; DULOXETINE; PAROXETINE; SEROTONIN TRANSPORTER;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; FRONTAL CORTEX; HIPPOCAMPUS; IN VITRO STUDY; LONG TERM EXPOSURE; MALE; MESENCEPHALON; NONHUMAN; NORADRENALIN RELEASE; OSMOTIC MINIPUMP; PYRAMIDAL NERVE CELL; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CARRIER PROTEINS; ELECTROPHYSIOLOGY; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PRESYNAPTIC TERMINALS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SYMPORTERS; THIOPHENES;

EID: 0031806233     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005214     Document Type: Article

References (44)

1. Austin MC, Bradley CC, Mann JJ, Arango V, Blakely RD (1993) Localization of serotonin transporter messenger RNA in the human brainstem. Soc Neurosci Abstr 22:4
2. 3H]nisoxetine autoradiography. Brain Res 582:208-214
3. Baumann PA, Waldmeier PC (1981) Further evidence for negative feedback control of serotonin release in the central nervous system. Naunyn Schmiedebergs Arch Pharmacol 317:36-43
4. Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243-245
5. Blier P, Bouchard C (1994) Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs. Br J Pharmacol 113:485-495
6. Blier P, de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220-226
7. Blier P, Chaput Y, de Montigny C (1988) Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 337:246-254
8. Blier P, Galzin AM, Langer SZ (1990) Interaction between serotonin uptake inhibitors and alpha-2 adrenergic heteroreceptors in the rat hypothalamus. J Pharmacol Exp Ther 254:236-244
9. Chaput Y, de Montigny C, Blier P (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 333:342-348
10. Chaput Y, de Montigny C, Blier P (1991) Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of untidepressant treatments: an in vivo electrophysiologic study in the rat. Neuropsychopharmacology 5:219-229
11. Curet O, de Montigny C (1988) Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. II. Receptors mediating the effect of synaptically released norepinephrine. Brain Res 475:47-57
12. de Montigny C, Wang RY, Reader TA, Aghajanian GK (1980) Monoaminergic denervation of the rat hippocampus: microiontophoretic studies on pre-and postsynaptic supersensitivity to norepinephrine and serotonin. Brain Res 200:363-376
13. El Mansari M, Bouchard C, Blier P (1995) Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors: relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacology 13:117-127
14. Engleman EA, Perry KW, Mayle DA, Wong DT (1995) Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor. Neuropsychopharmacology 12:287-295
15. Entsuah AR, Bradley MM, Littman GS (1994) Cumulative mean change procedure: application to a comparative trial of venlafaxine, imipramine and placebo in the treatment of major depression. Prog Neuropsychopharmacol Biol Psychiatry 18:695-706
16. 3H-serotonin release from slices of rat hippocampus. Eur J Pharmacol 63:179-182
17. 3H]5-hydroxytryptamine release from slices of the hippocampus of the rat. Eur J Pharmacol 81:97-106
18. Fuller RW, Hemrick-Luecke SK, Snoddy HD (1994) Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice. J Pharmacol Exp Ther 269:132-136
19. Göthert M, Huth H (1980) Alpha-adrenoceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol 313:21-26
20. Göthert M, Huth H, Schlicker E (1981) Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol 317:199-203
21. Guelfi JD, White C, Hackett D, Guichoux JY, Magni G (1995) Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia. J Clin Psychiatry 56:450-458
22. Haddjeri N, de Montigny C, Blier P (1997) Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxytryptamine system. Br J Pharmacol 120:865-875
23. Jacobs BL (1986) Single unit activity of brain monoamines-containing neurons in freely moving animals. Ann N Y Acad Sci 473:70-77
24. Kandel ER, Spencer WA (1961) Electrophysiology of hippocampal neurons. II. After potentials and repetitive firing. J Neurophysiol 24:243-259
25. Kasamo K, Blier P, de Montigny C (1996) Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain. J Pharmacol Exp Ther 277:278-286
26. Kihara T, Ikeda M (1995) Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex. J Pharmacol Exp Ther 272:177-183
27. Lacroix D, Blier P, Curet O, de Montigny C (1991) Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. J Pharmacol Exp Ther 257:1081-1090
28. Lavoie N, Debonnel G, de Montigny C, Béïque JC (1997) Affinities of reuptake inhibitors for the 5-HT and NE carriers: correlation with their potency for suppressing the firing activity of 5-HT and NE neurons. Soc Neurosci Abstr 23:1109
29. 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 347:266-272
30. 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology 10:41-51
31. 3H]5-HT from rat hypothalamic slices. Naunyn Schmiedebergs Arch Pharmacol 341: 398-403
32. Nelson JC, Mazure CM, Bowers MB, Jatlow PI (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 48:303-307
33. Nierenberg AA, Feighner JP, Rudolph R, Cole JO, Sullivan J (1994) Venlafaxine for treatment-resistant unipolar depression. J Clin Psychopharmacol 14:419-423
34. 1D receptors: effect of tetrodotoxin, G protein inactivation and long-term antidepressant administration. J Pharmacol Exp Ther 276:697-707
35. Piñeyro G, Blier P, Dennis T, de Montigny C (1994) Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14:3036-3047
36. Ramamoorthy S, Coll DR, Mahesh VB, Leibach FH, Melikian HE, Blakely RD, Ganapathy V (1993) Regulation of the human serotonin transporter. J Biol Chem 268:21626-21631
37. Ranck JB Jr (1973) Studies of single neurons in dorsal hippocampal formation and septum in unrestrained rats. I. Behavioral and firing repertoires. Exp Neurol 41:461-531
38. Rueter LE, de Montigny C, Blier P (1998) Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems. J Pharmacol Exp Ther (in press)
39. Schloss P, Betz H (1995) Heterogeneity of antidepressant binding sites on the recombinant rat serotonin transporter SERT1. Biochemistry 34:12590-12595
40. Seth R, Jennings AL, Bindman J, Phillips J, Bergmann K (1992) Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression. Br J Psychiatry 161:562-565
41. Starke K, Göthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69:864-988
42. Weilburg JB, Rosebaum JF, Biederman J, Sachs GS, Pollack MH, Kelly K (1989) Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry 50:447-449
43. Wong DT, Bymaster FP, Mayle DA, Reid LR, Kurshinski JH, Robertson DW (1993) LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology 8:23-33
44. Zajecka JM, Jeffriess H, Fawcett J (1995) The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis. J Clin Psychiatry 56:338-343